(CRSP) Crispr Therapeutics complete technical analysis [charts+indicators] | Buy/Sell Crispr Therapeutics | (CRSP) share price targets
Complete technical analysis of Crispr Therapeutics (CRSP) by charts plus indicators, forecast predictions and share price targets for Crispr Therapeutics (CRSP)
Crispr Therapeutics trades in USA in Health Care sector.
Showing technical analysis as on 2024-03-13 View latest technical analysis
10 day averaged volume of Crispr Therapeutics is 1580500
| Date | Daily Closing Price | Open | High | Low | Volume |
| 13 Wed Mar 2024 | 74.78 | 74.61 | 76.86 | 74.00 | 0.777 times |
| 12 Tue Mar 2024 | 75.30 | 76.20 | 76.20 | 73.66 | 0.892 times |
| 11 Mon Mar 2024 | 76.82 | 78.48 | 79.33 | 76.12 | 0.897 times |
| 08 Fri Mar 2024 | 78.92 | 79.54 | 81.73 | 77.10 | 1.022 times |
| 07 Thu Mar 2024 | 79.37 | 81.00 | 83.50 | 79.32 | 0.761 times |
| 06 Wed Mar 2024 | 80.83 | 81.58 | 81.98 | 79.50 | 0.69 times |
| 05 Tue Mar 2024 | 80.99 | 80.17 | 82.87 | 78.90 | 0.877 times |
| 04 Mon Mar 2024 | 81.74 | 83.98 | 84.17 | 80.50 | 1.015 times |
| 01 Fri Mar 2024 | 83.75 | 84.36 | 87.08 | 83.33 | 0.901 times |
| 29 Thu Feb 2024 | 84.22 | 89.39 | 89.88 | 83.04 | 1.596 times |
Although my analysis for stock is bearish for shortterm, but stock is in heavy over sold zones and there are high chances of some recovery tomorrow. You might want to buy the stock tomorrow in intra day with a stoploss of 73.4, for a target of 78 or 81.83
Share price targets for Crispr Therapeutics (CRSP)
| Target Type | Value |
| Downside Target | 39.76 |
| Downside Target | 55.21 |
| Downside Target | 58.29 |
| Downside Target | 62.08 |
| Downside Target | 68.48 |
| Downside Target | 73.66 |
| Upside Target | 76.19 |
| Upside Target | 79.33 |
| Upside Target | 83.04 |
| Upside Target | 87.08 |
| Upside Target | 90.18 |
| Upside Target | 90.62 |
| Upside Target | 91.10 |
Intraday share price targets for Crispr Therapeutics (CRSP)
| Target Type | Value |
| Downside Intraday Target | 72.52 |
| Downside Intraday Target | 70.25 |
| Upside Intraday Target | 78.19 |
| Upside Intraday Target | 81.59 |
| Upside Intraday Target | 75.92 |
Weekly technical analysis of Crispr Therapeutics (CRSP)
| Date | Weekly Closing Price | Open | High | Low | Volume |
| 13 Wed Mar 2024 | 74.78 | 78.48 | 79.33 | 73.66 | 0.588 times |
| 08 Fri Mar 2024 | 78.92 | 83.98 | 84.17 | 77.10 | 0.634 times |
| 01 Fri Mar 2024 | 83.75 | 83.49 | 90.62 | 83.04 | 0.935 times |
| 23 Fri Feb 2024 | 83.99 | 80.24 | 91.10 | 77.11 | 0.629 times |
| 16 Fri Feb 2024 | 82.22 | 70.03 | 90.18 | 69.80 | 2.191 times |
Price has moved down this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Crispr Therapeutics (CRSP)
| Date | Monthly Closing Price | Open | High | Low | Volume |
| 13 Wed Mar 2024 | 74.78 | 84.36 | 87.08 | 73.66 | 0.243 times |
| 29 Thu Feb 2024 | 84.22 | 63.49 | 91.10 | 62.08 | 1.159 times |
| 31 Wed Jan 2024 | 62.95 | 61.84 | 68.48 | 58.29 | 0.571 times |
| 29 Fri Dec 2023 | 62.60 | 66.22 | 76.97 | 55.21 | 1.148 times |
Scroll below to view daily charts
Price has moved down this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Crispr Therapeutics (CRSP)
Price action analysis of Crispr Therapeutics ( (CRSP) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Crispr Therapeutics ( (CRSP) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Crispr Therapeutics ( (CRSP) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Crispr Therapeutics ( (CRSP) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Crispr Therapeutics stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for Crispr Therapeutics in short term but the sell signal is initial and weak.
Crispr Therapeutics Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.
Ichimoku cloud is of green color and prices are in or below the green cloud Prices appear to be coming down
CCI has generated a buy signal for Crispr Therapeutics in short term but BUY signal is weak.
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Crispr Therapeutics is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 80.07 and Crispr Therapeutics (CRSP) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Crispr Therapeutics (CRSP) stock. Volume based technical analysis of Crispr Therapeutics (CRSP) stock is negative.
Crispr Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Crispr Therapeutics ( (CRSP) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Crispr Therapeutics ( (CRSP) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Crispr Therapeutics ( (CRSP) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Crispr Therapeutics ( (CRSP) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Crispr Therapeutics stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for Crispr Therapeutics in short term but the sell signal is initial and weak.
Crispr Therapeutics Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.
Ichimoku cloud is of green color and prices are in or below the green cloud Prices appear to be coming down
CCI has generated a buy signal for Crispr Therapeutics in short term but BUY signal is weak.
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Crispr Therapeutics is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 80.07 and Crispr Therapeutics (CRSP) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Crispr Therapeutics (CRSP) stock. Volume based technical analysis of Crispr Therapeutics (CRSP) stock is negative.
Crispr Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.